Aktie 4585 UMN PHARMA INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen UMN Pharma Inc.

Aktien

4585

JP3944320005

4585

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
AIM ImmunoTech Inc. Enters into Mutual Confidentiality Agreement with UMN Pharma Inc., Japan National Institute of Infectious Diseases, and Shionogi & Co., Ltd
Shionogi & Co., Ltd. completed the acquisition of 52.74% stake in UMN Pharma Inc. for ¥5 billion.
Shionogi & Co., Ltd. made a tender offer to acquire 69.6% stake in UMN Pharma Inc for approximately ¥6.7 billion.
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Six Months Ended June 30, 2019; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2019
UMN Pharma Inc. Reports Non-Consolidated Earnings Results for the Quarter Ended March 31, 2018; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2018
UMN Pharma Inc. Announces Non Consolidated Earnings Results for the Year Ended December 31, 2017; Provides Earnings Guidance for the Full Year of 2018
UMN Pharma Inc. announced that it has received ¥1.639 billion in funding from Shionogi & Co., Ltd.
UMN Pharma Inc. announced that it expects to receive ¥1.64 billion in funding from Shionogi & Co., Ltd.
Umn Pharma Inc. Announces Non-Consolidated Earnings Results for the Nine Months Ended September 30, 2017; Provides Earnings Guidance for the Fiscal Year Ending December. 31, 2017
UMN Pharma Inc.(TSE:4585) dropped from S&P Global BMI Index
UMN Pharma Inc. Announces Nonconsolidated Earnings Results for the Six Months Ended June 30, 2017; Provides Nonconsolidated Earnings Guidance for the Year Ending December 31, 2017
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2017; Provide Earnings Guidance for the Year 2017
UMN Pharma Inc. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2016; Provides Earnings Guidance for the Year Ending December 31, 2017
API Co., Ltd. acquired 50% stake in Unigen KK from UMN Pharma Inc..
Umn Pharma Inc. Announces Consolidated Earnings Results for the First Nine Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 31, 2016
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2016; Provides Earnings Guidance for the Year Ending December 31, 2016
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Quarter Ended March 31, 2016
UMN Pharma Inc. Announces Consolidated and Non-Consolidated Earnings Results for the Year Ended December 31, 2015
UMN Pharma Inc. Announces Consolidated Earnings Results for the First Nine Month Ended September 30, 2015; Updates Consolidated Earnings Guidance for the Year Ending March 31, 2016
UMN Pharma Inc. Announces Consolidated Earnings Results for the Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ending December 31, 2015
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 4585 Aktie
  4. Nachrichten UMN Pharma Inc.
  5. Andere Sprachen